Skip to main content

ORIGINAL RESEARCH article

Front. Oncol., 10 September 2020
Sec. Pharmacology of Anti-Cancer Drugs
Volume 10 - 2020 | https://doi.org/10.3389/fonc.2020.01756
This article is part of the Research Topic Natural Products as a Tool to Design New anti-MDR Lead Molecules View all 12 articles

RETRACTED: Combination of Tanshinone IIA and Cisplatin Inhibits Esophageal Cancer by Downregulating NF-κB/COX-2/VEGF Pathway

Updated

A retraction of this article was approved in:

  1. Retraction: Combination of Tanshinone IIA and Cisplatin Inhibits Esophageal Squamous Cell Carcinoma by Down-Regulating NF-kB/COX-2/VEGF Pathway

    1. Read retraction

  2. RETRACTED: Corrigendum: Combination of Tanshinone IIA and Cisplatin Inhibits Esophageal Cancer by Downregulating NF-κB/COX-2/VEGF Pathway

    1. Read correction
\r\nXiaozhong Liao,,&#x;Xiaozhong Liao1,2,3†Ying Gao&#x;Ying Gao1†Jiahui Liu,&#x;Jiahui Liu1,3†Lanting TaoLanting Tao1Dongmei WangDongmei Wang4Dan Xie*Dan Xie2*Suilin Mo*Suilin Mo1*
  • 1Department of Traditional Chinese Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China
  • 2The State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China
  • 3Department of Oncology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China
  • 4School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, China

This article has been retracted. Please follow the link to the full retraction notice for details.

Citation: Liao X, Gao Y, Liu J, Tao L, Xie J, Gu Y, Liu T, Wang D, Xie D and Mo S (2020) Combination of Tanshinone IIA and Cisplatin Inhibits Esophageal Cancer by Downregulating NF-κB/COX-2/VEGF Pathway. Front. Oncol. 10:1756. doi: 10.3389/fonc.2020.01756

Received: 06 February 2020; Accepted: 05 August 2020;
Published: 10 September 2020; Retracted: 29 June 2021.

Edited by:

Francisco Estévez, University of Las Palmas de Gran Canaria, Spain

Reviewed by:

Diwakar Bastihalli Tukaramrao, University of Toledo, United States
Zui Pan, University of Texas at Arlington, United States

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.